PharMerica CORP SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease)
PharMerica CORP reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease) of -$2.50 million for the 12-month period ending 2016-12-31, per its 10-Q filed 2017-05-10.
Discontinued › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease · last filed 2017-05-10
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease) 12 month |
|---|---|
| 2016-12-31 | -$2.50M 10-Q · filed 2017-05-10 |